{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:28:46Z","timestamp":1779913726752,"version":"3.53.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National\u00a0Natural\u00a0Science\u00a0Foundation\u00a0of\u00a0China","doi-asserted-by":"crossref","award":["No.\u00a081801812"],"award-info":[{"award-number":["No.\u00a081801812"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The number of elderly patients with early renal cell carcinoma (RCC) is on the rise. However, there is still a lack of accurate prediction models for the prognosis of early RCC in elderly patients. It is necessary to establish a new nomogram to predict the prognosis of elderly patients with early RCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The data of patients aged above 65\u00a0years old with TNM stage I and II RCC were downloaded from the SEER database between 2010 and 2018. The patients from 2010 to 2017 were randomly assigned to the training cohort (n\u2009=\u20097233) and validation cohort (n\u2009=\u20093024). Patient data in 2018(n\u2009=\u20091360) was used for external validation. We used univariable and multivariable Cox regression model to evaluate independent prognostic factors and constructed a nomogram to predict the 1-, 3-, and 5-year overall survival (OS) rates of patients with early-stage RCC. Multiple parameters were used to validate the nomogram, including the consistency index (C-index), the calibration plots, the area under the receiver operator characteristics (ROC) curve, and the decision curve analysis (DCA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study included a total of 11,617 elderly patients with early RCC. univariable and multivariable Cox regression analysis based on predictive variables such as age, sex, histologic type, Fuhrman grade, T stage, surgery type, tumors number, tumor size, and marriage were included to establish a nomogram. The C-index of the training cohort and validation cohort were 0.748 (95% CI: 0.760\u20130.736) and 0.744 (95% CI: 0.762\u20130.726), respectively. In the external validation cohort, C-index was 0.893 (95% CI: 0.928\u20130.858). The calibration plots basically coincides with the diagonal, indicating that the observed OS was almost equal to the predicted OS. It was shown in DCA that the nomogram has more important clinical significance than the traditional TNM stage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A novel nomogram was developed to assess the prognosis of an elderly patient with early RCC and to predict prognosis and formulate treatment and follow-up strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-022-03287-w","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T13:03:11Z","timestamp":1644843791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A web-based prediction model for overall survival of elderly patients with early renal cell carcinoma: a population-based study"],"prefix":"10.1186","volume":"20","author":[{"given":"Jinkui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiaoyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7800-3100","authenticated-orcid":false,"given":"Xiaozhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"issue":"5","key":"3287_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386. https:\/\/doi.org\/10.1002\/ijc.29210.","journal-title":"Int J Cancer"},{"key":"3287_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41392-019-0074-5","volume":"4","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Tang H, Chen P, Xie H, Tao Y. Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome. Signal Transduct Target Ther. 2019;4:41. https:\/\/doi.org\/10.1038\/s41392-019-0074-5.","journal-title":"Signal Transduct Target Ther."},{"issue":"1","key":"3287_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21590.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"3287_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/PPO.0b013e3181867628","volume":"14","author":"WH Chow","year":"2008","unstructured":"Chow WH, Devesa SS. Contemporary epidemiology of renal cell cancer. Cancer J. 2008;14(5):288\u2013301. https:\/\/doi.org\/10.1097\/PPO.0b013e3181867628.","journal-title":"Cancer J"},{"issue":"9669","key":"3287_CR5","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","volume":"373","author":"BI Rini","year":"2009","unstructured":"Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet. 2009;373(9669):1119\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(09)60229-4.","journal-title":"Lancet"},{"issue":"4","key":"3287_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMra1601333","volume":"376","author":"TK Choueiri","year":"2017","unstructured":"Choueiri TK, Motzer RJ. Systemic therapy for metastatic renal-cell carcinoma. N Engl J Med. 2017;376(4):354\u201366. https:\/\/doi.org\/10.1056\/NEJMra1601333.","journal-title":"N Engl J Med"},{"key":"3287_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1477-7819-5-16","volume":"5","author":"S Denzinger","year":"2007","unstructured":"Denzinger S, Otto W, Burger M, et al. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates? World J Surg Oncol. 2007;5:16. https:\/\/doi.org\/10.1186\/1477-7819-5-16.","journal-title":"World J Surg Oncol"},{"issue":"4","key":"3287_CR8","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.eururo.2006.10.025","volume":"51","author":"X Taccoen","year":"2007","unstructured":"Taccoen X, Valeri A, Descotes JL, et al. Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival. Eur Urol. 2007;51(4):980\u20137. https:\/\/doi.org\/10.1016\/j.eururo.2006.10.025.","journal-title":"Eur Urol"},{"issue":"5","key":"3287_CR9","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.eururo.2006.11.056","volume":"51","author":"G Verhoest","year":"2007","unstructured":"Verhoest G, Veillard D, Guill\u00e9 F, et al. Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma. Eur Urol. 2007;51(5):1298\u2013305. https:\/\/doi.org\/10.1016\/j.eururo.2006.11.056.","journal-title":"Eur Urol"},{"issue":"2","key":"3287_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/00365590701571555","volume":"42","author":"A Thoroddsen","year":"2008","unstructured":"Thoroddsen A, Einarsson GV, Hardarson S, et al. Renal cell carcinoma in young compared to older patients: comparison of clinicopathological risk factors and survival. Scand J Urol Nephrol. 2008;42(2):121\u20135. https:\/\/doi.org\/10.1080\/00365590701571555.","journal-title":"Scand J Urol Nephrol"},{"issue":"18","key":"3287_CR11","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/jnci\/djj362","volume":"98","author":"JM Hollingsworth","year":"2006","unstructured":"Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98(18):1331\u20134. https:\/\/doi.org\/10.1093\/jnci\/djj362.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"3287_CR12","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.juro.2013.12.046","volume":"191","author":"SC King","year":"2014","unstructured":"King SC, Pollack LA, Li J, King JB, Master VA. Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010. J Urol. 2014;191(6):1665\u201370. https:\/\/doi.org\/10.1016\/j.juro.2013.12.046.","journal-title":"J Urol"},{"issue":"13","key":"3287_CR13","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1002\/cncr.25184","volume":"116","author":"BR Lane","year":"2010","unstructured":"Lane BR, Abouassaly R, Gao T, et al. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older. Cancer. 2010;116(13):3119\u201326. https:\/\/doi.org\/10.1002\/cncr.25184.","journal-title":"Cancer"},{"issue":"1","key":"3287_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.eururo.2013.03.034","volume":"65","author":"M Sun","year":"2014","unstructured":"Sun M, Becker A, Tian Z, et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol. 2014;65(1):235\u201341. https:\/\/doi.org\/10.1016\/j.eururo.2013.03.034.","journal-title":"Eur Urol"},{"issue":"2","key":"3287_CR15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/1097-0142(20010115)91:2<354::aid-cncr1009>3.0.co;2-9","volume":"91","author":"MT Gettman","year":"2001","unstructured":"Gettman MT, Blute ML, Spotts B, Bryant SC, Zincke H. Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system. Cancer. 2001;91(2):354\u201361. https:\/\/doi.org\/10.1002\/1097-0142(20010115)91:2%3c354::aid-cncr1009%3e3.0.co;2-9.","journal-title":"Cancer"},{"issue":"4","key":"3287_CR16","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.juro.2009.12.035","volume":"183","author":"BC Leibovich","year":"2010","unstructured":"Leibovich BC, Lohse CM, Crispen PL, et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol. 2010;183(4):1309\u201315. https:\/\/doi.org\/10.1016\/j.juro.2009.12.035.","journal-title":"J Urol"},{"issue":"1","key":"3287_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12967-019-1940-1","volume":"17","author":"Y Yan","year":"2019","unstructured":"Yan Y, Liu H, Mao K, et al. Novel nomograms to predict lymph node metastasis and liver metastasis in patients with early colon carcinoma. J Transl Med. 2019;17(1):193. https:\/\/doi.org\/10.1186\/s12967-019-1940-1.","journal-title":"J Transl Med."},{"key":"3287_CR18","doi-asserted-by":"publisher","first-page":"e919789","DOI":"10.12659\/MSM.919789","volume":"26","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Xie H, Chen P, Cao P. Development and Identification of a nomogram prognostic model for patients with primary clear cell carcinoma of the liver. Med Sci Monit. 2020;26:e919789. https:\/\/doi.org\/10.12659\/MSM.919789.","journal-title":"Med Sci Monit."},{"issue":"4","key":"3287_CR19","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173\u201380. https:\/\/doi.org\/10.1016\/S1470-2045(14)71116-7.","journal-title":"Lancet Oncol"},{"issue":"4","key":"3287_CR20","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/jso.25644","volume":"120","author":"I van den Hoven","year":"2019","unstructured":"van den Hoven I, van Klaveren D, Verheuvel NC, et al. Predicting the extent of nodal involvement for node positive breast cancer patients: development and validation of a novel tool. J Surg Oncol. 2019;120(4):578\u201386. https:\/\/doi.org\/10.1002\/jso.25644.","journal-title":"J Surg Oncol"},{"issue":"3","key":"3287_CR21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.chest.2018.04.040","volume":"154","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zheng D, Xie J, et al. Development and validation of web-based nomograms to precisely predict conditional risk of site-specific recurrence for patients with completely resected non-small cell lung cancer: a multiinstitutional study. Chest. 2018;154(3):501\u201311. https:\/\/doi.org\/10.1016\/j.chest.2018.04.040.","journal-title":"Chest"},{"issue":"1","key":"3287_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00330-018-5539-3","volume":"29","author":"T Hu","year":"2019","unstructured":"Hu T, Wang S, Huang L, et al. A clinical-radiomics nomogram for the preoperative prediction of lung metastasis in colorectal cancer patients with indeterminate pulmonary nodules. Eur Radiol. 2019;29(1):439\u201349. https:\/\/doi.org\/10.1007\/s00330-018-5539-3.","journal-title":"Eur Radiol"},{"issue":"Suppl 23","key":"3287_CR23","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1002\/cncr.29049","volume":"120","author":"KA Cronin","year":"2014","unstructured":"Cronin KA, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. Cancer. 2014;120(Suppl 23):3755\u20137. https:\/\/doi.org\/10.1002\/cncr.29049.","journal-title":"Cancer"},{"key":"3287_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1472-6947-8-53","volume":"8","author":"AJ Vickers","year":"2008","unstructured":"Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008;8:53. https:\/\/doi.org\/10.1186\/1472-6947-8-53.","journal-title":"BMC Med Inform Decis Mak."},{"issue":"19","key":"3287_CR25","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","volume":"373","author":"RJ Motzer","year":"2015","unstructured":"Motzer RJ, Escudier B, McDermott DF, et al. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. N Engl J Med. 2015;373(19):1803\u201313. https:\/\/doi.org\/10.1056\/NEJMoa1510665.","journal-title":"N Engl J Med"},{"key":"3287_CR26","doi-asserted-by":"publisher","first-page":"18810","DOI":"10.3402\/meo.v17i0.18810","volume":"17","author":"A Brateanu","year":"2012","unstructured":"Brateanu A, Yu C, Kattan MW, Olender J, Nielsen C. A nomogram to predict the probability of passing the American Board of Internal Medicine examination. Med Educ Online. 2012;17:18810. https:\/\/doi.org\/10.3402\/meo.v17i0.18810.","journal-title":"Med Educ Online."},{"key":"3287_CR27","doi-asserted-by":"publisher","first-page":"26684","DOI":"10.1038\/srep26684","volume":"6","author":"J Cao","year":"2016","unstructured":"Cao J, Yuan P, Wang L, et al. Clinical Nomogram for Predicting Survival of Esophageal Cancer Patients after Esophagectomy. Sci Rep. 2016;6:26684. https:\/\/doi.org\/10.1038\/srep26684.","journal-title":"Sci Rep."},{"issue":"1\u20136","key":"3287_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/CBM-2011-0176","volume":"9","author":"P Cairns","year":"2010","unstructured":"Cairns P. Renal cell carcinoma. Cancer Biomark. 2010;9(1\u20136):461\u201373. https:\/\/doi.org\/10.3233\/CBM-2011-0176.","journal-title":"Cancer Biomark"},{"issue":"7","key":"3287_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41581-019-0131-x","volume":"15","author":"C Porta","year":"2019","unstructured":"Porta C, Cosmai L, Leibovich BC, Powles T, Gallieni M, Bex A. The adjuvant treatment of kidney cancer: a multidisciplinary outlook. Nat Rev Nephrol. 2019;15(7):423\u201333. https:\/\/doi.org\/10.1038\/s41581-019-0131-x.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"3287_CR30","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jos.2017.07.006","volume":"22","author":"A Yoshiyama","year":"2017","unstructured":"Yoshiyama A, Morii T, Susa M, et al. Preoperative evaluation of renal cell carcinoma patients with bone metastases on risks for blood loss, performance status and lethal event. J Orthop Sci. 2017;22(5):924\u201330. https:\/\/doi.org\/10.1016\/j.jos.2017.07.006.","journal-title":"J Orthop Sci"},{"issue":"4","key":"3287_CR31","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.clinre.2017.02.008","volume":"41","author":"H Zhou","year":"2017","unstructured":"Zhou H, Zhang Y, Song Y, et al. Marital status is an independent prognostic factor for pancreatic neuroendocrine tumors patients: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database. Clin Res Hepatol Gastroenterol. 2017;41(4):476\u201386. https:\/\/doi.org\/10.1016\/j.clinre.2017.02.008.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"3287_CR32","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3892\/or.2018.6529","volume":"40","author":"X Huang","year":"2018","unstructured":"Huang X, Shu C, Chen L, Yao B. Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer. Oncol Rep. 2018;40(3):1359\u201369. https:\/\/doi.org\/10.3892\/or.2018.6529.","journal-title":"Oncol Rep"},{"issue":"1","key":"3287_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0022-5347(05)66077-6","volume":"166","author":"MW Kattan","year":"2001","unstructured":"Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol. 2001;166(1):63\u20137.","journal-title":"J Urol"},{"issue":"2","key":"3287_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0022-5347(05)00148-5","volume":"175","author":"SN Chawla","year":"2006","unstructured":"Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175(2):425\u201331. https:\/\/doi.org\/10.1016\/S0022-5347(05)00148-5.","journal-title":"J Urol"},{"issue":"5","key":"3287_CR35","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.urology.2003.11.037","volume":"63","author":"DA Taub","year":"2004","unstructured":"Taub DA, Miller DC, Cowan JA, Dimick JB, Montie JE, Wei JT. Impact of surgical volume on mortality and length of stay after nephrectomy. Urology. 2004;63(5):862\u20137. https:\/\/doi.org\/10.1016\/j.urology.2003.11.037.","journal-title":"Urology"},{"issue":"7","key":"3287_CR36","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/cncr.24035","volume":"115","author":"L Zini","year":"2009","unstructured":"Zini L, Perrotte P, Capitanio U, et al. Radical versus partial nephrectomy: effect on overall and noncancer mortality. Cancer. 2009;115(7):1465\u201371. https:\/\/doi.org\/10.1002\/cncr.24035.","journal-title":"Cancer"},{"issue":"2","key":"3287_CR37","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.juro.2007.09.077","volume":"179","author":"RH Thompson","year":"2008","unstructured":"Thompson RH, Boorjian SA, Lohse CM, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol. 2008;179(2):468\u201373. https:\/\/doi.org\/10.1016\/j.juro.2007.09.077.","journal-title":"J Urol"},{"key":"3287_CR38","doi-asserted-by":"publisher","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [published correction appears in N Engl J Med. 2008;18(4):4]. N Engl J Med. 2004;351(13):1296\u20131305. doi: https:\/\/doi.org\/10.1056\/NEJMoa041031.","DOI":"10.1056\/NEJMoa041031"},{"issue":"9","key":"3287_CR39","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1470-2045(06)70803-8","volume":"7","author":"WC Huang","year":"2006","unstructured":"Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7(9):735\u201340. https:\/\/doi.org\/10.1016\/S1470-2045(06)70803-8.","journal-title":"Lancet Oncol"},{"issue":"12","key":"3287_CR40","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.4065\/75.12.1236","volume":"75","author":"WK Lau","year":"2000","unstructured":"Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000;75(12):1236\u201342. https:\/\/doi.org\/10.4065\/75.12.1236.","journal-title":"Mayo Clin Proc"},{"key":"3287_CR41","doi-asserted-by":"publisher","unstructured":"Miller DC, Schonlau M, Litwin MS, Lai J, Saigal CS; Urologic Diseases in America Project. Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer. 2008;112(3):511\u2013520. doi: https:\/\/doi.org\/10.1002\/cncr.23218.","DOI":"10.1002\/cncr.23218"},{"issue":"1","key":"3287_CR42","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1158\/0008-5472.CAN-18-1089","volume":"79","author":"DJ Crona","year":"2019","unstructured":"Crona DJ, Skol AD, Lepp\u00e4nen VM, et al. Genetic Variants of VEGFA and FLT4 are determinants of survival in renal cell carcinoma patients treated with sorafenib. Cancer Res. 2019;79(1):231\u201341. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-1089.","journal-title":"Cancer Res"},{"key":"3287_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ctrv.2017.08.010","volume":"60","author":"A S\u00e1nchez-Gastaldo","year":"2017","unstructured":"S\u00e1nchez-Gastaldo A, Kempf E, Gonz\u00e1lez Del Alba A, Duran I. Systemic treatment of renal cell cancer: a comprehensive review. Cancer Treat Rev. 2017;60:77\u201389. https:\/\/doi.org\/10.1016\/j.ctrv.2017.08.010.","journal-title":"Cancer Treat Rev"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03287-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03287-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03287-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T13:08:35Z","timestamp":1644844115000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03287-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3287"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03287-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"assertion":[{"value":"31 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data of this study is obtained from the SEER database. The patients\u2019 data is public and anonymous, so this study does not require ethical approval and informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent for participate"}},{"value":"All authors have reviewed the final version of the manuscript and approved its submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflicts of interest in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}